Description
Uso tras confirmación molecular de mutación EGFR
162 ML Aceite Envase
PRINCIPIO ACTIVO: SIMVASTATINA - EZETIMIBA
PRINCIPIO ACTIVO: DIOSMINA HESPERIDINA
PRINCIPIO ACTIVO: PIOGLITAZONA
CETAPHIL ANTIBAC BRRA 127G PERINDOPRIL (TERBUTILAMINA) Uso tras confirmación molecular deDOSIS: 127 G PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
OMURO 40MG TAB C15 DILTIAZEM 30.00 MG
US$ 303.06
BAUL YW125/BWS125 ORIGINAL H41200-KWF-840K/0
US$ 40400.00
OMRON NEBULIZADOR NIÑOS PASTEUR
US$ 621.25
OLEODERM BABY CRA 120ML ABBOTT MEDICINAL
US$ 184.16
CAJA PORTACASCO NMAX ORIGINAL Y5LM-F2141-00
US$ 100750.00
OXORAL GEL ANTISEP BCAL 28G LATEX
US$ 165.64
OPTIMIN JBE 240ML CERA ALB
US$ 320.45
SOBRE TAPA GAS YW125 ORIGINAL H17910-437-000/0
US$ 3000.00
OXATHOS 1G JBE 115ML CETILPIRIDINIO 1.45 MG
US$ 161.03
![[DV5627] Womens Crossfit Nano 2.0 Size:10](https://cdn.shopify.com/s/files/1/0013/0164/3322/products/DV5627_01_b2bc7599-7935-44b1-a882-95f785f7abe0.jpg?v=1602079107)




